Skip to main content

Table 4 Serum levels of PAI-1 in HCC patients and controls

From: Plasminogen activator inhibitor (PAI-1) gene polymorphism (4G/5G) and hepatocellular carcinoma in Egyptian patients

Genotype

Serum PAI, ng/mL (mean ± SD)

p valuea

n

HCC patients

n

Control

5G/5G

12

24.75 ± 11.53

12

20.17 ± 11.46

0.260

4G/4G

9

25.89 ± 11.83

11

22.09 ± 11.95

0.446

4G/5G

29

25.93 ± 10.92

24

26.92 ± 9.92

0.508

Total

50

25.64 ± 10.91

47

24.06 ± 10.99

0.480c

p valueb

 

0.911

 

0.264

 
  1. PAI-1 platelet activating inhibitor-1
  2. aMann-Whitney test
  3. bKruskal-Wallis test
  4. cStudent’s t test